Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jackson, SL; Peterson, GM; Vial, JH; Daud, R; Ang, SY
   Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice
   INTERNAL MEDICINE JOURNAL
   
   S.L. Jackson et al., "Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice", INTERN M J, 31(6), 2001, pp. 329-336
2. Durrington, PN; Mackness, B; Mackness, MI
   Paraoxonase and atherosclerosis
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   P.N. Durrington et al., "Paraoxonase and atherosclerosis", ART THROM V, 21(4), 2001, pp. 473-480
3. August, M
   Cerebrovascular and carotid artery disease
   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
   
   M. August, "Cerebrovascular and carotid artery disease", ORAL SURG O, 92(3), 2001, pp. 253-256
4. Gabig, TG
   Prevention of arterial thromboembolism in nonvalvular atrial fibrillation:Validating molecular markers of risk stratification
   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
   
   T.G. Gabig, "Prevention of arterial thromboembolism in nonvalvular atrial fibrillation:Validating molecular markers of risk stratification", J CARD ELEC, 12(8), 2001, pp. 885-886
5. Bornstein, NM
   Antiplatelet drugs: How to select them and possibilities of combined treatment
   CEREBROVASCULAR DISEASES
   
   N.M. Bornstein, "Antiplatelet drugs: How to select them and possibilities of combined treatment", CEREB DIS, 11, 2001, pp. 96-99
6. Taylor, FC; Cohen, H; Ebrahim, S
   Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation
   BRITISH MEDICAL JOURNAL
   
   F.C. Taylor et al., "Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation", BR MED J, 322(7282), 2001, pp. 321-326
7. Vainio, H; Bianchini, F
   Prevention of disease with pharmaceuticals
   PHARMACOLOGY & TOXICOLOGY
   
   H. Vainio e F. Bianchini, "Prevention of disease with pharmaceuticals", PHARM TOX, 88(3), 2001, pp. 111-118
8. Weisbord, SD; Whittle, J; Brooks, RC
   Is warfarin really underused in patients with atrial fibrillation?
   JOURNAL OF GENERAL INTERNAL MEDICINE
   
   S.D. Weisbord et al., "Is warfarin really underused in patients with atrial fibrillation?", J GEN INT M, 16(11), 2001, pp. 743-749
9. Hylek, EM
   Oral anticoagulants - Pharmacologic issues for use in the elderly
   CLINICS IN GERIATRIC MEDICINE
   
   E.M. Hylek, "Oral anticoagulants - Pharmacologic issues for use in the elderly", CLIN GERIAT, 17(1), 2001, pp. 1
10. Beyth, RJ
    Hemorrhagic complications of oral anticoagulant therapy
    CLINICS IN GERIATRIC MEDICINE
    
    R.J. Beyth, "Hemorrhagic complications of oral anticoagulant therapy", CLIN GERIAT, 17(1), 2001, pp. 49
11. Singer, DE; Go, AS
    Antithrombotic therapy in atrial fibrillation
    CLINICS IN GERIATRIC MEDICINE
    
    D.E. Singer e A.S. Go, "Antithrombotic therapy in atrial fibrillation", CLIN GERIAT, 17(1), 2001, pp. 131
12. Moll, R; Dinkel, HP
    Value of the CT angiography in the diagnosis of common carotid artery bifurcation disease: CT angiography versus digital subtraction angiography and color flow Doppler
    EUROPEAN JOURNAL OF RADIOLOGY
    
    R. Moll e H.P. Dinkel, "Value of the CT angiography in the diagnosis of common carotid artery bifurcation disease: CT angiography versus digital subtraction angiography and color flow Doppler", EUR J RAD, 39(3), 2001, pp. 155-162
13. Aikimbaev, K; Guvenc, B; Canataroglu, A; Canataroglu, H; Baslamisli, F; Oguz, M
    Value of duplex and color Doppler ultrasonography in the evaluation of orbital vascular flow and resistance in sickle cell disease
    AMERICAN JOURNAL OF HEMATOLOGY
    
    K. Aikimbaev et al., "Value of duplex and color Doppler ultrasonography in the evaluation of orbital vascular flow and resistance in sickle cell disease", AM J HEMAT, 67(3), 2001, pp. 163-167
14. Bennett, JS; Mousa, S
    Platelet function inhibitors in the year 2000
    THROMBOSIS AND HAEMOSTASIS
    
    J.S. Bennett e S. Mousa, "Platelet function inhibitors in the year 2000", THROMB HAEM, 85(3), 2001, pp. 395-400
15. Diener, HC; Darius, H; Bertrand-Hardy, JM; Humphreys, M
    Cardiac events during secondary stroke prevention with dipyridamole
    ZEITSCHRIFT FUR KARDIOLOGIE
    
    H.C. Diener et al., "Cardiac events during secondary stroke prevention with dipyridamole", Z KARDIOL, 90(5), 2001, pp. 348-351
16. Wandell, PE
    A survey of subjects with present or previous atrial fibrillation in a Swedish community
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
    
    P.E. Wandell, "A survey of subjects with present or previous atrial fibrillation in a Swedish community", SC J PRIM H, 19(1), 2001, pp. 20-24
17. Bartres-Faz, D; Junque, C; Clemente, IC; Serra-Grabulosa, JM; Guardia, J; Lopez-Alomar, A; Sanchez-Aldeguer, J; Mercader, JM; Bargallo, N; Olondo, M; Moral, P
    MRI and genetic correlates of cognitive function in elders with memory impairment
    NEUROBIOLOGY OF AGING
    
    D. Bartres-Faz et al., "MRI and genetic correlates of cognitive function in elders with memory impairment", NEUROBIOL A, 22(3), 2001, pp. 449-459
18. Schmidt, R; Schmidt, H; Fazekas, F; Launer, LJ; Niederkorn, K; Kapeller, P; Lechner, A; Kostner, GM
    Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities
    HYPERTENSION
    
    R. Schmidt et al., "Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities", HYPERTENSIO, 38(1), 2001, pp. 110-115
19. Cohen, N; Almoznino-Sarafian, D; Alon, I; Gorelik, O; Koopfer, M; Chachashvily, S; Shteinshnaider, M; Litvinjuk, V; Modai, D
    Adequacy of anticoagulation in patients with atrial fibrillation: Effect of various parameters
    CLINICAL CARDIOLOGY
    
    N. Cohen et al., "Adequacy of anticoagulation in patients with atrial fibrillation: Effect of various parameters", CLIN CARD, 24(5), 2001, pp. 380-384
20. Abdelhafiz, AH
    A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation
    CLINICAL THERAPEUTICS
    
    A.H. Abdelhafiz, "A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation", CLIN THER, 23(10), 2001, pp. 1628-1636
21. Kurl, S; Laukkanen, JA; Rauramaa, R; Lakka, TA; Sivenius, J; Salonen, JT
    Systolic blood pressure response to exercise stress test and risk of stroke
    STROKE
    
    S. Kurl et al., "Systolic blood pressure response to exercise stress test and risk of stroke", STROKE, 32(9), 2001, pp. 2036-2041
22. Morgenstern, LB; Steffen-Batey, L; Smith, MA; Moye, LA
    Barriers to acute stroke therapy and stroke prevention in Mexican Americans
    STROKE
    
    L.B. Morgenstern et al., "Barriers to acute stroke therapy and stroke prevention in Mexican Americans", STROKE, 32(6), 2001, pp. 1360-1364
23. Zotz, RJ; Muller, M; Genth-Zotz, S; Darius, H
    Spontaneous echo contrast caused by platelet and leukocyte aggregates?
    STROKE
    
    R.J. Zotz et al., "Spontaneous echo contrast caused by platelet and leukocyte aggregates?", STROKE, 32(5), 2001, pp. 1127-1133
24. Lamassa, M; Di Carlo, A; Pracucci, G; Basile, AM; Trefoloni, G; Vanni, P; Spolveri, S; Baruffi, MC; Landini, G; Ghetti, A; Wolfe, CDA; Inzitari, D
    Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe - Data from a multicenter multinational hospital-based registry (the European Community Stroke Project)
    STROKE
    
    M. Lamassa et al., "Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe - Data from a multicenter multinational hospital-based registry (the European Community Stroke Project)", STROKE, 32(2), 2001, pp. 392-398
25. Evans, A; Perez, I; Yu, G; Kalra, L
    Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
    STROKE
    
    A. Evans et al., "Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?", STROKE, 32(12), 2001, pp. 2828-2832
26. Wilterdink, JL; Bendixen, B; Adams, HP; Woolson, RF; Clarke, WR; Hansen, MD
    Effect of prior aspirin use on stroke severity in the trial of Org 10172 in Acute Stroke Treatment (TOAST)
    STROKE
    
    J.L. Wilterdink et al., "Effect of prior aspirin use on stroke severity in the trial of Org 10172 in Acute Stroke Treatment (TOAST)", STROKE, 32(12), 2001, pp. 2836-2840
27. Billings-Gagliardi, S; Fontneau, NM; Wolf, MK; Barrett, SV; Hademenos, G; Mazor, KM
    Educating the next generation of physicians about stroke - Incorporating stroke prevention into the medical school curriculum
    STROKE
    
    S. Billings-Gagliardi et al., "Educating the next generation of physicians about stroke - Incorporating stroke prevention into the medical school curriculum", STROKE, 32(12), 2001, pp. 2854-2858
28. Bains, JS; Follwell, MJ; Latchford, KJ; Anderson, JW; Ferguson, AV
    Slowly inactivating potassium conductance (I-D) - A potential target for stroke therapy
    STROKE
    
    J.S. Bains et al., "Slowly inactivating potassium conductance (I-D) - A potential target for stroke therapy", STROKE, 32(11), 2001, pp. 2624-2634
29. Hart, CL; Hole, DJ; Smith, GD
    Are two really better than one? Empirical examination of repeat blood pressure measurements and stroke risk in the Renfrew/Pitisley and collaborativestudies
    STROKE
    
    C.L. Hart et al., "Are two really better than one? Empirical examination of repeat blood pressure measurements and stroke risk in the Renfrew/Pitisley and collaborativestudies", STROKE, 32(11), 2001, pp. 2697-2699
30. Phan, T; Huston, J; Bernstein, MA; Riederer, SJ; Brown, RD
    Contrast-enhanced magnetic resonance angiography of the cervical vessels -Experience with 422 patients
    STROKE
    
    T. Phan et al., "Contrast-enhanced magnetic resonance angiography of the cervical vessels -Experience with 422 patients", STROKE, 32(10), 2001, pp. 2282-2286
31. Feasby, TE; Quan, H; Ghali, WA
    Geographic variation in the rate of carotid endarterectomy in Canada
    STROKE
    
    T.E. Feasby et al., "Geographic variation in the rate of carotid endarterectomy in Canada", STROKE, 32(10), 2001, pp. 2417-2421
32. Falk, RH
    Medical progress: Atrial fibrillation.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    R.H. Falk, "Medical progress: Atrial fibrillation.", N ENG J MED, 344(14), 2001, pp. 1067-1078
33. Dumont, AS; Hyndman, E; Dumont, RJ; Fedak, PM; Kassell, NF; Sutherland, GR; Verma, S
    Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin
    JOURNAL OF NEUROSURGERY
    
    A.S. Dumont et al., "Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin", J NEUROSURG, 95(3), 2001, pp. 466-471
34. McCormick, D; Gurwitz, JH; Goldberg, RJ; Becker, R; Tate, JP; Elwell, A; Radford, MJ
    Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting
    ARCHIVES OF INTERNAL MEDICINE
    
    D. McCormick et al., "Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting", ARCH IN MED, 161(20), 2001, pp. 2458-2463
35. Copland, M; Walker, ID; Tait, RC
    Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation
    ARCHIVES OF INTERNAL MEDICINE
    
    M. Copland et al., "Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation", ARCH IN MED, 161(17), 2001, pp. 2125-2128
36. Evans, A; Kalra, L
    Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?
    ARCHIVES OF INTERNAL MEDICINE
    
    A. Evans e L. Kalra, "Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?", ARCH IN MED, 161(11), 2001, pp. 1443-1447
37. Cohen, A
    The best of echocardiography in 2000
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX
    
    A. Cohen, "The best of echocardiography in 2000", ARCH MAL C, 94, 2001, pp. 27-39
38. den Heijer, T; Launer, LJ; de Groot, JG; de Leeuw, FE; Oudkerk, M; van Gijn, J; Hofman, A; Breteler, MMB
    Serum carotenoids and cerebral white matter lesions: The Rotterdam Scan Study
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    
    T. den Heijer et al., "Serum carotenoids and cerebral white matter lesions: The Rotterdam Scan Study", J AM GER SO, 49(5), 2001, pp. 642-646
39. Szolnoki, Z; Somogyvari, F; Kondacs, A; Szabo, M; Fodor, L
    Evaluation of the roles of common genetic mutations in leukoaraiosis
    ACTA NEUROLOGICA SCANDINAVICA
    
    Z. Szolnoki et al., "Evaluation of the roles of common genetic mutations in leukoaraiosis", ACT NEUR SC, 104(5), 2001, pp. 281-287
40. New, G; Roubin, GS; Iyer, SS; Vitek, JJ; Wholey, MH; Diethrich, EB; Hopkins, LN; Hobson, RW; Leon, MB; Myla, SV; Shawl, F; Ramee, SR; Yadav, JS; Rosenfield, K; Liu, MW; Gomez, CR; Al-Mubarak, N; Gray, WA; Tan, WA; Goldstein, JE; Stack, RS
    Safety, efficacy, and durability of carotid artery stenting for restenosisfollowing carotid endarterectomy: A multicenter study
    JOURNAL OF ENDOVASCULAR THERAPY
    
    G. New et al., "Safety, efficacy, and durability of carotid artery stenting for restenosisfollowing carotid endarterectomy: A multicenter study", J ENDOVAS T, 7(5), 2000, pp. 345-352
41. Pasini, L; Capecchi, PL; Di Perri, T
    Adenosine and chronic ischemia of the lower limbs
    VASCULAR MEDICINE
    
    L. Pasini et al., "Adenosine and chronic ischemia of the lower limbs", VASC MED, 5(4), 2000, pp. 243-250
42. Teng, MP; Catherwood, E; Melby, DP
    Cost effectiveness of therapies for atrial fibrillation - A review
    PHARMACOECONOMICS
    
    M.P. Teng et al., "Cost effectiveness of therapies for atrial fibrillation - A review", PHARMACOECO, 18(4), 2000, pp. 317-333
43. Hayes, PD; Lloyd, AJ; Lennard, N; Wolstenholme, JL; London, NJM; Bell, PRF; Naylor, AR
    Transcranial Doppler-directed Dextran-40 therapy is a cost-effective method of preventing carotid thrombosis after carotid endarterectomy
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    
    P.D. Hayes et al., "Transcranial Doppler-directed Dextran-40 therapy is a cost-effective method of preventing carotid thrombosis after carotid endarterectomy", EUR J VAS E, 19(1), 2000, pp. 56-61
44. Lenz, TL; Hilleman, DE
    Aggrenox: A fixed-dose combination of aspirin and dipyridamole
    ANNALS OF PHARMACOTHERAPY
    
    T.L. Lenz e D.E. Hilleman, "Aggrenox: A fixed-dose combination of aspirin and dipyridamole", ANN PHARMAC, 34(11), 2000, pp. 1283-1290
45. Bhatt, DL; Kapadia, SR; Yadav, JS; Topol, EJ
    Update on clinical trials of antiplatelet therapy for cerebrovascular diseases
    CEREBROVASCULAR DISEASES
    
    D.L. Bhatt et al., "Update on clinical trials of antiplatelet therapy for cerebrovascular diseases", CEREB DIS, 10, 2000, pp. 34-40
46. Johnson, WD; Ganjoo, AK; Stone, CD; Srivyas, RC; Howard, M
    The left atrial appendage: our most lethal human attachment! Surgical implications
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    
    W.D. Johnson et al., "The left atrial appendage: our most lethal human attachment! Surgical implications", EUR J CAR-T, 17(6), 2000, pp. 718-722
47. Matchar, DB; Samsa, GP; Cohen, SJ; Oddone, EZ
    Community impact of anticoagulation services: Rationale and design of the Managing Anticoagulation Services Trial (MAST)
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    D.B. Matchar et al., "Community impact of anticoagulation services: Rationale and design of the Managing Anticoagulation Services Trial (MAST)", J THROMB TH, 9(1), 2000, pp. S7-S11
48. Segal, JB; McNamara, RL; Miller, MR; Kim, N; Goodman, SN; Powe, NR; Robinson, KA; Bass, EB
    Prevention of thromboembolism in atrial fibrillation - A meta-analysis of trials of anticoagulants and antiplatelet drugs
    JOURNAL OF GENERAL INTERNAL MEDICINE
    
    J.B. Segal et al., "Prevention of thromboembolism in atrial fibrillation - A meta-analysis of trials of anticoagulants and antiplatelet drugs", J GEN INT M, 15(1), 2000, pp. 56-67
49. Hart, RG
    Anticoagulation therapy for patients with atrial fibrillation
    CANADIAN MEDICAL ASSOCIATION JOURNAL
    
    R.G. Hart, "Anticoagulation therapy for patients with atrial fibrillation", CAN MED A J, 163(8), 2000, pp. 956-957
50. Guilmot, JL; Diot, E; Gruel, Y
    Contribution of platelet antiaggregates in the prevention of complicationsof atherothrombosis
    PRESSE MEDICALE
    
    J.L. Guilmot et al., "Contribution of platelet antiaggregates in the prevention of complicationsof atherothrombosis", PRESSE MED, 29(13), 2000, pp. 709-716
51. Patel, AM; Westveer, DC; Man, KC; Stewart, JR; Frumin, HI
    Treatment of underlying atrial fibrillation: Paced rhythm obscures recognition
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    
    A.M. Patel et al., "Treatment of underlying atrial fibrillation: Paced rhythm obscures recognition", J AM COL C, 36(3), 2000, pp. 784-787
52. Picano, E; Abbracchio, MP
    Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector
    BRAIN RESEARCH BULLETIN
    
    E. Picano e M.P. Abbracchio, "Adenosine, the imperfect endogenous anti-ischemic cardio-neuroprotector", BRAIN RES B, 52(2), 2000, pp. 75-82
53. Hacke, W; Kaste, M; Olsen, TS; Orgogozo, JM; Bogousslavsky, J
    European Stroke Initiative: recommendations for stroke management - Organisation of stroke care
    JOURNAL OF NEUROLOGY
    
    W. Hacke et al., "European Stroke Initiative: recommendations for stroke management - Organisation of stroke care", J NEUROL, 247(9), 2000, pp. 732-748
54. Chaturvedi, S; Meinke, JL; St Pierre, E; Bertasio, B
    Attitudes of Canadian and US neurologists regarding carotid endarterectomyfor asymptomatic stenosis
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    S. Chaturvedi et al., "Attitudes of Canadian and US neurologists regarding carotid endarterectomyfor asymptomatic stenosis", CAN J NEUR, 27(2), 2000, pp. 116-119
55. Schmidt, R; Roob, G; Kapeller, P; Schmidt, H; Berghold, A; Lechner, A; Fazekas, F
    Longitudinal change of white matter abnormalities
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    
    R. Schmidt et al., "Longitudinal change of white matter abnormalities", J NEUR TR-S, (59), 2000, pp. 9-14
56. Schmidt, H; Fazekas, F; Kostner, GM; Schmidt, R
    Genetic aspects of microangiopathy-related cerebral damage
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    
    H. Schmidt et al., "Genetic aspects of microangiopathy-related cerebral damage", J NEUR TR-S, (59), 2000, pp. 15-21
57. Bungard, TJ; Ackman, ML; Ho, G; Tsuyuki, RT
    Adequacy of anticoagulation in patients with atrial fibrillation coming toa hospital
    PHARMACOTHERAPY
    
    T.J. Bungard et al., "Adequacy of anticoagulation in patients with atrial fibrillation coming toa hospital", PHARMACOTHE, 20(9), 2000, pp. 1060-1065
58. Gordon, DL
    The Mississippi Stroke Education Consortium: A state-based template to promote stroke awareness, prevention and emergency treatment
    NEUROEPIDEMIOLOGY
    
    D.L. Gordon, "The Mississippi Stroke Education Consortium: A state-based template to promote stroke awareness, prevention and emergency treatment", NEUROEPIDEM, 19(1), 2000, pp. 1-12
59. Crassard, I; Niclot, P; Bousser, MG
    Aspirin and cerebral infarction.
    REVUE DE MEDECINE INTERNE
    
    I. Crassard et al., "Aspirin and cerebral infarction.", REV MED IN, 21, 2000, pp. 41S-49S
60. Ringelstein, EB; Nabavi, D
    Long-term prevention of ischaemic stroke and stroke recurrence
    THROMBOSIS RESEARCH
    
    E.B. Ringelstein e D. Nabavi, "Long-term prevention of ischaemic stroke and stroke recurrence", THROMB RES, 98(3), 2000, pp. V83-V96
61. Redfern, J; McKevitt, C; Dundas, R; Rudd, AG; Wolfe, CDA
    Behavioral risk factor prevalence and lifestyle change after stroke - A prospective study
    STROKE
    
    J. Redfern et al., "Behavioral risk factor prevalence and lifestyle change after stroke - A prospective study", STROKE, 31(8), 2000, pp. 1877-1881
62. Hart, CL; Hole, DJ; Smith, GD
    Comparison of risk factors for stroke incidence and stroke mortality in 20years of follow-up in men and women in the Renfrew/Paisley study in Scotland
    STROKE
    
    C.L. Hart et al., "Comparison of risk factors for stroke incidence and stroke mortality in 20years of follow-up in men and women in the Renfrew/Paisley study in Scotland", STROKE, 31(8), 2000, pp. 1893-1896
63. Hirono, N; Yasuda, M; Tanimukai, S; Kitagaki, H; Mori, E
    Effect of the apolipoprotein E epsilon 4 allele on white matter hyperintensities in dementia
    STROKE
    
    N. Hirono et al., "Effect of the apolipoprotein E epsilon 4 allele on white matter hyperintensities in dementia", STROKE, 31(6), 2000, pp. 1263-1268
64. Gage, BF; Boechler, M; Doggette, AL; Fortune, G; Flaker, GC; Rich, MW; Radford, MJ
    Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation
    STROKE
    
    B.F. Gage et al., "Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation", STROKE, 31(4), 2000, pp. 822-827
65. Hughes, RL
    Supplement to the AHA Guidelines for the Management of Transient Ischemic Attacks
    STROKE
    
    R.L. Hughes, "Supplement to the AHA Guidelines for the Management of Transient Ischemic Attacks", STROKE, 31(4), 2000, pp. 983-984
66. Estrada, CA; Hryniewicz, MM; Higgs, VB; Collins, C; Byrd, JC
    Anticoagulant patient information material is written at high readability levels
    STROKE
    
    C.A. Estrada et al., "Anticoagulant patient information material is written at high readability levels", STROKE, 31(12), 2000, pp. 2966-2970
67. Ellekjaer, H; Holmen, J; Ellekjaer, E; Vatten, L
    Physical activity and stroke mortality in women - Ten-year follow-up of the Nord-Trondelag Health Survey, 1984-1986
    STROKE
    
    H. Ellekjaer et al., "Physical activity and stroke mortality in women - Ten-year follow-up of the Nord-Trondelag Health Survey, 1984-1986", STROKE, 31(1), 2000, pp. 14-18
68. Kumar, S; Osman, IS; Woollard, CJ; Cameron, AEP
    'Fast track' carotid duplex scanning in a district general hospital
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND
    
    S. Kumar et al., "'Fast track' carotid duplex scanning in a district general hospital", ANN RC SURG, 82(3), 2000, pp. 167-170
69. Albers, GW
    Choice of endpoints in antiplatelet trials - Which outcomes are most relevant to stroke patients?
    NEUROLOGY
    
    G.W. Albers, "Choice of endpoints in antiplatelet trials - Which outcomes are most relevant to stroke patients?", NEUROLOGY, 54(5), 2000, pp. 1022-1028
70. Zhu, KM; Hunter, S; Bernard, LJ; Payne-Wilks, K; Roland, CL; Levine, RS
    Recruiting elderly African-American women in cancer prevention and controlstudies: A multifaceted approach and its effectiveness
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
    
    K.M. Zhu et al., "Recruiting elderly African-American women in cancer prevention and controlstudies: A multifaceted approach and its effectiveness", J NAT MED A, 92(4), 2000, pp. 169-175
71. Ferrer, VF; Abad, OL; Saez, DI; Vega, CP; Reina, D; Rosello, J; Iglesias, JR; Garcia, AS; Martin, JA; Ribosa, TFD
    Analysis of factors associated with the indication of anticoagulant therapy in chronic atrial fibrillation. Prospective study of 170 patients admitted to an Internal Medicine Department
    REVISTA CLINICA ESPANOLA
    
    V.F. Ferrer et al., "Analysis of factors associated with the indication of anticoagulant therapy in chronic atrial fibrillation. Prospective study of 170 patients admitted to an Internal Medicine Department", REV CLIN ES, 200(4), 2000, pp. 203-207
72. Gariballa, SE
    Nutritional factors in stroke
    BRITISH JOURNAL OF NUTRITION
    
    S.E. Gariballa, "Nutritional factors in stroke", BR J NUTR, 84(1), 2000, pp. 5-17
73. Bungard, TJ; Ghali, WA; Teo, KK; McAlister, FA; Tsuyuki, RT
    Why do patients with atrial fibrillation not receive warfarin?
    ARCHIVES OF INTERNAL MEDICINE
    
    T.J. Bungard et al., "Why do patients with atrial fibrillation not receive warfarin?", ARCH IN MED, 160(1), 2000, pp. 41-46
74. Li-Saw-Hee, FL; Lip, GYH
    Atrial fibrillation, thromboembolism and antithrombotic therapy
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    F.L. Li-Saw-Hee e G.Y.H. Lip, "Atrial fibrillation, thromboembolism and antithrombotic therapy", INT J CL PR, 53(2), 1999, pp. 110-117
75. Perez, I; Melbourn, A; Kalra, L
    Use of antithrombotic measures for stroke prevention in atrial fibrillation
    HEART
    
    I. Perez et al., "Use of antithrombotic measures for stroke prevention in atrial fibrillation", HEART, 82(5), 1999, pp. 570-574
76. Lodwick, A
    Warfarin therapy: A review of the literature since the Fifth American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    
    A. Lodwick, "Warfarin therapy: A review of the literature since the Fifth American College of Chest Physicians' Consensus Conference on Antithrombotic Therapy", CL APPL T-H, 5(4), 1999, pp. 208-215
77. Hankey, GJ
    Stroke prediction and prevention by carotid endarterectomy: Keep an eye onthe doughnut and not just the hole
    CEREBROVASCULAR DISEASES
    
    G.J. Hankey, "Stroke prediction and prevention by carotid endarterectomy: Keep an eye onthe doughnut and not just the hole", CEREB DIS, 9(6), 1999, pp. 345-350
78. Santoliquido, A; Gaetani, E; Gerardino, L; Gasbarrini, A; Pola, R
    Post-traumatic basilar artery thrombosis in a young man with atrial septumaneurysm and prothrombin gene G20210A polymorphism
    BLOOD COAGULATION & FIBRINOLYSIS
    
    A. Santoliquido et al., "Post-traumatic basilar artery thrombosis in a young man with atrial septumaneurysm and prothrombin gene G20210A polymorphism", BL COAG FIB, 10(6), 1999, pp. 389-392
79. Boysen, G
    Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis
    JOURNAL OF INTERNAL MEDICINE
    
    G. Boysen, "Bleeding complications in secondary stroke prevention by antiplatelet therapy: a benefit-risk analysis", J INTERN M, 246(3), 1999, pp. 239-245
80. McCormick, D; Gurwitz, JH; Goldberg, RJ; Ansell, J
    Long-term anticoagulation therapy for atrial fibrillation in elderly patients: Efficacy, risk, and current patterns of use
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    D. McCormick et al., "Long-term anticoagulation therapy for atrial fibrillation in elderly patients: Efficacy, risk, and current patterns of use", J THROMB TH, 7(2), 1999, pp. 157-163
81. Gorelick, PB; Erkinjuntti, T; Hofman, A; Rocca, WA; Skoog, I; Winblad, B
    Prevention of vascular dementia
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    
    P.B. Gorelick et al., "Prevention of vascular dementia", ALZ DIS A D, 13, 1999, pp. S131-S139
82. Warshafsky, S; Packard, D; Marks, SJ; Sachdeva, N; Terashita, DM; Kaufman, G; Song, K; Deluca, AJ; Peterson, SJ; Frishman, WH
    Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors forprevention of stroke
    JOURNAL OF GENERAL INTERNAL MEDICINE
    
    S. Warshafsky et al., "Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors forprevention of stroke", J GEN INT M, 14(12), 1999, pp. 763-774
83. Rochon, PA; Clark, JP; Gurwitz, JH
    Challenges of prescribing low-dose drug therapy for older people
    CANADIAN MEDICAL ASSOCIATION JOURNAL
    
    P.A. Rochon et al., "Challenges of prescribing low-dose drug therapy for older people", CAN MED A J, 160(7), 1999, pp. 1029-1031
84. Sander, D
    New aspects of stroke prevention
    NERVENHEILKUNDE
    
    D. Sander, "New aspects of stroke prevention", NERVENHEILK, 18(9), 1999, pp. 460-466
85. Constans, J; Sampoux, F; Jarnier, P; Le Metayer, P; Midy, D; Morlat, P; Bakhach, S; Longy-Boursier, M; Le Bras, M; Beylot, J; Baste, JC; Conri, C
    Hemorrhagic complications of antivitamin K treatment in a series of 75 patients.
    JOURNAL DES MALADIES VASCULAIRES
    
    J. Constans et al., "Hemorrhagic complications of antivitamin K treatment in a series of 75 patients.", J MAL VASC, 24(3), 1999, pp. 202-207
86. Koudstaal, PJ
    Stroke prevention: which drugs to use and when?
    JOURNAL OF NEUROLOGY
    
    P.J. Koudstaal, "Stroke prevention: which drugs to use and when?", J NEUROL, 246(9), 1999, pp. 753-757
87. Theis, JGW; Deichsel, G; Marshall, S
    Rapid development of tolerance to dipyridamole-associated headaches
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    J.G.W. Theis et al., "Rapid development of tolerance to dipyridamole-associated headaches", BR J CL PH, 48(5), 1999, pp. 750-755
88. Coccheri, S; Palareti, G; Cosmi, B
    Oral anticoagulant therapy: Efficacy, safety and the low-dose controversy
    HAEMOSTASIS
    
    S. Coccheri et al., "Oral anticoagulant therapy: Efficacy, safety and the low-dose controversy", HAEMOSTASIS, 29(2-3), 1999, pp. 150-165
89. Oswald, N; Bateman, H
    Applying research evidence to individuals in primary care: a study using non-rheumatic atrial fibrillation
    FAMILY PRACTICE
    
    N. Oswald e H. Bateman, "Applying research evidence to individuals in primary care: a study using non-rheumatic atrial fibrillation", FAM PRACT, 16(4), 1999, pp. 414-419
90. Harker, LA; Boissel, JP; Pilgrim, AJ; Gent, M
    Comparative safety and tolerability of clopidogrel and aspirin - Results from CAPRIE
    DRUG SAFETY
    
    L.A. Harker et al., "Comparative safety and tolerability of clopidogrel and aspirin - Results from CAPRIE", DRUG SAFETY, 21(4), 1999, pp. 325-335
91. Gorelick, PB; Born, GVR; D'Agostino, RB; Hanley, DF; Moye, L; Pepine, CJ
    Therapeutic benefit - Aspirin revisited in light of the introduction of clopidogrel
    STROKE
    
    P.B. Gorelick et al., "Therapeutic benefit - Aspirin revisited in light of the introduction of clopidogrel", STROKE, 30(8), 1999, pp. 1716-1721
92. Evenson, KR; Rosamond, WD; Cai, JW; Toole, JF; Hutchinson, RG; Shahar, E; Folsom, AR
    Physical activity and ischemic stroke risk - The Atherosclerosis Risk in Communities Study
    STROKE
    
    K.R. Evenson et al., "Physical activity and ischemic stroke risk - The Atherosclerosis Risk in Communities Study", STROKE, 30(7), 1999, pp. 1333-1339
93. Hart, RG; Pearce, LA; McBride, R; Rothbart, RM; Asinger, RW
    Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation - Analysis of 2012 participants in the SPAF I-III clinical trials
    STROKE
    
    R.G. Hart et al., "Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation - Analysis of 2012 participants in the SPAF I-III clinical trials", STROKE, 30(6), 1999, pp. 1223-1229
94. Stern, EB; Berman, ME; Thomas, JJ; Klassen, AC
    Community education for stroke awareness - An efficacy study
    STROKE
    
    E.B. Stern et al., "Community education for stroke awareness - An efficacy study", STROKE, 30(4), 1999, pp. 720-723
95. Fang, XH; Kronmal, RA; Li, SC; Longstreth, WT; Cheng, XM; Wang, WZ; Wu, SP; Du, XL; Siscovick, D
    Prevention of stroke in urban China - A community-based intervention trial
    STROKE
    
    X.H. Fang et al., "Prevention of stroke in urban China - A community-based intervention trial", STROKE, 30(3), 1999, pp. 495-501
96. Fuster, V
    The American Stroke Association - A division of the American Heart Association
    STROKE
    
    V. Fuster, "The American Stroke Association - A division of the American Heart Association", STROKE, 30(2), 1999, pp. 281-281
97. Albers, GW; Hart, RG; Lutsep, HL; Newell, DW; Sacco, RL
    Supplement to the guidelines for the management of transient ischemic attacks - A statement from the Ad Hoc Committee on guidelines for the management of transient ischemic attacks, Stroke Council, American Heart Association
    STROKE
    
    G.W. Albers et al., "Supplement to the guidelines for the management of transient ischemic attacks - A statement from the Ad Hoc Committee on guidelines for the management of transient ischemic attacks, Stroke Council, American Heart Association", STROKE, 30(11), 1999, pp. 2502-2511
98. Hart, CL; Hole, DJ; Smith, GD
    Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland
    STROKE
    
    C.L. Hart et al., "Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland", STROKE, 30(10), 1999, pp. 1999-2007
99. Lee, IM; Hennekens, CH; Berger, K; Buring, JE; Manson, JE
    Exercise and risk of stroke in male physicians
    STROKE
    
    I.M. Lee et al., "Exercise and risk of stroke in male physicians", STROKE, 30(1), 1999, pp. 1-6
100. Joseph, LN; Babikian, VL; Allen, NC; Winter, MR
     Risk factor modification,in stroke prevention - The experience of a strokeclinic
     STROKE
     
     L.N. Joseph et al., "Risk factor modification,in stroke prevention - The experience of a strokeclinic", STROKE, 30(1), 1999, pp. 16-20